Abstract
Adipose tissue has been considered an important endocrine organ. Adiponectin secretes from adipose tissue and plays an important role in the regulation of glycemia, β‐oxidation in muscle, and decreased insulin resistance in the liver. The objectives of this study were to compare the levels of adiponectin, hs‐C‐reactive protein (CRP), HbA1c, and blood lipids among diabetic and healthy postmenopausal women, and to determine the relationship between circulating adiponectin and development of type II diabetes. This case‐control study was performed on 28 diabetic and 42 age‐matched healthy women. All participants were postmenopausal. Serum adiponectin concentrations, serum triglycerides (TG), cholesterol, low‐density lipoprotein cholesterol (LDL‐C), and high‐density lipoprotein cholesterol (HDL‐C) concentrations were determined. Blood HbA1c and serum hs‐CRP were also measured. Adiponectin levels were significantly decreased (P<0.01) in the diabetic patients as compared to normal control subjects. Adiponectin levels were negatively associated with hs‐CRP, LDL‐C, HbA1c, TG, and total cholesterol (TC). A positive correlation was observed between adiponectin and HDL‐C. The obtained data indicate that diabetic women have lower adiponectin levels compared to healthy women. HbA1c as an indicator of glycemic control has a negative correlation with serum adiponectin. Adiponectin may play an important role in the pathogenesis of diabetes, and may be an independent predictor of the development of diabetes in women. J. Clin. Lab. Anal. 21:197–200, 2007. © 2007 Wiley‐Liss, Inc.
Keywords: adiponectin, hs‐CRP, glycated hemoglobin
REFERENCES
- 1. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003;26:3226–3229. [DOI] [PubMed] [Google Scholar]
- 2. Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponectin mutation with type 2 diabetes. Diabetes 2002;51:2325–2328. [DOI] [PubMed] [Google Scholar]
- 3. Mantzoros C, Li T, Manson J, Meigs J, Hu F. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005;372:1–22. [DOI] [PubMed] [Google Scholar]
- 4. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentration predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239–243. [DOI] [PubMed] [Google Scholar]
- 5. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin metabolic risk factors, and cardiovascular events among patient with end‐stage renal disease. J Am Soc Nephrol 2002;13:134–141. [DOI] [PubMed] [Google Scholar]
- 6. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G. Young men with high‐normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002;25:971–976. [DOI] [PubMed] [Google Scholar]
- 7. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type II diabetes in Japanese population: the Funagata study. Diabetes 2003;26:2015–2020. [DOI] [PubMed] [Google Scholar]
- 8. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in Pima Indian population. Lancet 2002;360:57–58. [DOI] [PubMed] [Google Scholar]
- 9. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226–228. [DOI] [PubMed] [Google Scholar]
- 10. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin more than just another fat cell hormone? Diabetes Care 2003;26:2442–2450. [DOI] [PubMed] [Google Scholar]
- 11. Berg AH, Combs TP, Scherer PE. ACR30/adiponectin: an adipokine regulating glucose and lipids metabolism. Trends Endocrinol Metab 2002;13:84–89. [DOI] [PubMed] [Google Scholar]
- 12. Jaleel F, Jaleel A, Aftab J, Rahman MA. Relationship between adiponectin and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease. Clin Chim Acta 2006;370:76–81. [DOI] [PubMed] [Google Scholar]
- 13. National Diabetes Data Group . Classification and diagnosis of diabetes mellitus and other category of glucose intolerance. Diabetes 1979;28:1039–1057. [DOI] [PubMed] [Google Scholar]
- 14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502. [PubMed] [Google Scholar]
- 15. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930–1935. [DOI] [PubMed] [Google Scholar]
- 16. Matsubara M, Maruoka S, Katayose. Decreased plasma adiponectin concentration in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764–2769. [DOI] [PubMed] [Google Scholar]
- 17. Ryan AS, Berman DM, Nicklas BJ, Katayose S. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003;26:2383–2388. [DOI] [PubMed] [Google Scholar]
- 18. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentration of adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkey. Diabetes 2001;50:1126–1133. [DOI] [PubMed] [Google Scholar]
- 19. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosin phosphorylation, and low plasma concentration precedes a decrease in whole‐body insulin sensitivity in human. Diabetes 2002;51:1884–1888. [DOI] [PubMed] [Google Scholar]
- 20. Zurawska‐Klis M, Drzewoski J. Inflammatory markers and adiponectin plasma level in patients with type 2 diabetes. Pol Arch Med Wewn 2005;114:652–657. [PubMed] [Google Scholar]
- 21. Yamauchi T, Kamon J, Waki H, et al. The fat‐derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941–946. [DOI] [PubMed] [Google Scholar]